Canopy Care, an Israeli medtech startup that offers an Intelligent Care Platform (ICP) for oncology, raised $13 million in funding led by GSR Ventures, with participation from Samsung Next, UpWest. Canopy also came out of stealth, making its platform generally available to cancer treatment centers across the U.S.
Israel Startup Nation is known for a wide variety of high tech fields, from cyber security to new green technologies. One of the areas that it is also known for is medtech, which refers to just about any newly developed medical technology, from the devices used by doctors to new types of software for managing doctors’ files and so on. And Canopy Care is in good company. Earlier this month, MDClone, an Israeli medtech startup and digital health company, raised $63 million in a Series C round of funding. And XRHealth, an Israeli medtech startup that calls itself the gateway to virtual healthcare treatment in the metaverse, raised $10 million in new funding.
Founded in 2017, Canopy Care says that its Intelligent Care Platform powers an “entire layer of interoperable software solutions” over the EMR and Practice Management systems that enables providers to deliver higher quality care to more patients at lower cost. Canopy boasts that it can deliver continuous care to every patient, regardless of practice size, and improve patient experience and outcomes while optimizing for practice success in today’s rapidly changing oncology landscape.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at email@example.com.
“Canopy’s mission is to provide every person undergoing cancer treatment with the best possible outcomes and experience,” said Lavi Kwiatkowsky, founder and CEO of Canopy Care. “We have already demonstrated in cancer treatment centers across the US that a proactive care delivery model is not only possible but effective. Now, we are focused on expanding our presence nationwide while increasingly deploying artificial intelligence to maximize the benefits we deliver to patients and their care teams.”
“Oncology practices have been using manual processes in an effort to improve patient care for over 20 years, and have had very little impact on practice efficiency, or patient outcomes,” said Michael Kolodziej, MD, Head of Medical Oncology at Canopy Care. “The systems we’ve been using were created to optimize documentation and billing, and it’s time we had a software platform built for care. Canopy does just that by enabling providers to deploy life-saving interventions in a scalable way, build deeper relationships, and proactively care for patients.”